Targeting CBX3 with a Dual BET/PLK1 Inhibitor Enhances the Antitumor Efficacy of CDK4/6 Inhibitors in Prostate Cancer
Huaiyuan Liang(Central South University), Xin Jin(Wuhan Union Hospital)
Cited by 19
Related Papers
Smoking-associated upregulation of CBX3 suppresses ARHGAP24 expression to activate Rac1 signaling and promote tumor progression in lung adenocarcinoma
|Oncogene|2021|61
Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1/EZH2 complex in pancreatic cancer
|Cell Death and Disease|2021|57
PES1 promotes BET inhibitors resistance and cells proliferation through increasing c-Myc expression in pancreatic cancer
|Journal of Experimental & Clinical Cancer Research|2019|50
The FOXM1/RNF26/p57 axis regulates the cell cycle to promote the aggressiveness of bladder cancer
|Cell Death and Disease|2021|40
The YTHDC1/GLUT3/RNF183 axis forms a positive feedback loop that modulates glucose metabolism and bladder cancer progression
|Experimental & Molecular Medicine|2023|31